- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04950738
The Effectiveness of Acupuncture for Complications in Critically Ill Patients
The Effectiveness of Acupuncture for Complications in Critically Ill Patients: Multiple Centers a Double-Blind Randomized Control Trial
Introduction:
Intensive care unit (ICU) is a special department in the health care facility. Although with high development of modern medicine nowadays, the average mortality rate in ICU is still around 7 to 20 %. There are a few tricky problems that intensivists and ICU nurses faced very often, including ICU delirium, arrhythmia and poor digestion problem that will all affect the mortality and morbidity rate of critical care patients.
Methods: A randomized control trial will examine the effect of press tack acupuncture vs. press tack placebos. The patients will be randomly divided (1:1) into one of two groups. A total of 80 ICU patients will have to meet the following criteria: age 20-90, newly ICU admission(<48 hours), APACHE score <30, one or no inotropic medicine use, FiO2< 60%. Three interventions will be given in each group. The main outcomes will be the incidence of arrhythmia, delirium, and poor digestion and the severity of pain. We will also record ICU mortality, ICU stays and hospital days.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Introduction:
Intensive care unit (ICU) is a special department in the health care facility. Although with high development of modern medicine nowadays, the average mortality rate in ICU is still around 7 to 20 %. There are a few tricky problems that intensivists and ICU nurses faced very often, including ICU delirium, arrhythmia and poor digestion problem that will all affect the mortality and morbidity rate of critical care patients.
Methods: A randomized control trial will examine the effect of press tack acupuncture vs. press tack placebos. The patients will be randomly divided (1:1) into one of two groups. A total of 80 ICU patients will have to meet the following criteria: age 20-90, newly ICU admission(<48 hours), APACHE score <30, one or no inotropic medicine use, FiO2< 60%. Three interventions will be given in each group. The main outcomes will be the incidence of arrhythmia, delirium, and poor digestion and the severity of pain. We will also record ICU mortality, ICU stays and hospital days.
Expected outcome: The study finding will help to determine the therapeutic effect of acupuncture for ICU complications.
Other information: This study will be conducted in the ICU departments of China medical hospital and Asia University Hospital, Taichung city, Taiwan. The study is conducted on stable ICU patients and we don't anticipate any serious risk for adverse events following the intervention.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yu-Chen Lee
- Phone Number: 04-22052121
- Email: d5167@mail.cmuh.org.tw
Study Contact Backup
- Name: Peiyu Kao
- Phone Number: 04-22052121
- Email: ludouto@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Age 20--90
- newly ICU admission (<48 hours)
- APACHE score <30
- Less than 3 inotropic medicine use
- Fi02< 60%.
Exclusion Criteria:
• Coagulopathy: Prolong Prothrombin Time (PPT) activated Partial Thromboplastin Time (aPTT) more than 4 times
- Thrombocytopenia - low platelet count
- Clinically unstable: receiving two or more inotropic agents or Fraction of Inspired Oxygen (Fi02) >60%
- Primary central nervous system disorder: stroke, traumatic brain injury, central nervous system infections, brain tumors, recent intracranial surgery
- Already under other traditional medicine intervention during hospitalization
- Skin damage of more than 20% of the body skin.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Acupuncture with press tack needle group (Acu)
Patients in acupuncture group will receive traditional Chinese acupuncture using Press Tack Needle (PYONEX 0.20 x l.5mm made by Seirin Corporation).
The following acupoints will be used: HT 7 (Shen Men), PC 6 (Nei Guan), LU 9 (Tai yuan), LI 4 (He Gu), SP 3 (Tai Bai,) ST 44 (Nei ting), LIV 3 (Tai Chong).
The treatment will use bilateral acupuncture Interventions will be given on day 1, 3, and 5 after patient's enrolment.
|
Patients enrolled will receive intervention in a form of either press tack acupuncture needles or press tack placebos.
Three total intervention sessions will be taken place on day 1,3,5 from patient's enrolment.
Needles/placebos skin withdrawal will be done 48 hours after treatment by an acupuncture doctor or by a trained ICU nurne.
In cases when a patient will be transferred from the ICU, the 3 study interventions will be continued in the new ward.
Other Names:
|
|
Placebo Comparator: Placebo group press tack placebo (Con)
Patients randomized to the control group will receive a press lack placebo (made by Seirin Corporation), which looks identical to press tack needles but, with no needle element.
The point selection will be identical to the acupuncture group: HT 7 (Shen Men), PC 6 (Nei Guan), LU 9 (Tai yuan), L1 4 (He Gu), SP 3; (Tat Bai), ST 44 (Ne1 tmg), LIV 3 (Tat Chong).
Interventions will be given on days 1, 3, and 5 after the patient's enrolment.
|
pess tack stickers without a needle
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
arrhythmia
Time Frame: at the patient's ICU discharge, on average 1 week
|
incidence of arrhythmia
|
at the patient's ICU discharge, on average 1 week
|
|
delirium
Time Frame: at the patient's ICU discharge, on average 1 week
|
4 or more points according to the Intensive Care Delirium Screening Checklist (ICDSC)(0-8 scale, score of less than 4 points indicate no delirium, 4 or more indicate delirium) and a Richmond Agitation-Sedation Scale (RASS) score of: +l, +2, +3, +4 - 1, -2 (score meanings +1 - 4 = levels of agitation, -1-4= levels of sudation, 0 = normal mental state.
|
at the patient's ICU discharge, on average 1 week
|
|
feeding intolorance
Time Frame: at the patient's ICU discharge, on average 1 week
|
measured by days to reach the target Energy Fxpenditure
|
at the patient's ICU discharge, on average 1 week
|
|
pain in the intensive care unit (ICU)
Time Frame: at the patient's ICU discharge, on average 1 week
|
For pain the Numeric Rating scale will be applied in patients that are able to express their self.
As well as the Behavioral pain scale.
The Critical Care Pain Observation Tool (CPOT) 0-8, will also be filled by the doctor and nurses along with the dose of fentanyl, hydromorphone methadone, morphine, and remifentanil and other analgesic medications.
|
at the patient's ICU discharge, on average 1 week
|
|
dose of arrhythmia drugs
Time Frame: at the patient's ICU discharge, on average 1 week
|
the dose of Adenosine, calcium channel blockers, or beta-blocking agents or other arrhythmia drugs . |
at the patient's ICU discharge, on average 1 week
|
|
dose of use of prokinetic drugs
Time Frame: at the patient's ICU discharge, on average 1 week
|
does of metoclopramide, Erythromycin or other prokinetic drugs
|
at the patient's ICU discharge, on average 1 week
|
|
analgesic medication use
Time Frame: at the patient's ICU discharge, on average 1 week
|
dose of fentanyl, hydromorphone methadone, morphine, and remifentanil and other analgesic medications.
|
at the patient's ICU discharge, on average 1 week
|
|
delirium drug use
Time Frame: at the patient's ICU discharge, on average 1 week
|
addition to drug use (a daily dose of sedative drugs, muscle relaxant, or atypical antipsychotics IV Haloperidol Benzodiazepines, Precedex, Propofol and oral Quediapine)
|
at the patient's ICU discharge, on average 1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the use of Parental nutrition
Time Frame: at the patient's ICU discharge, on average 1 week
|
patients who cannot digest with daily NG tube: drainage: more than 500ml per day or severe diarrhea more the 1000 ml per day
|
at the patient's ICU discharge, on average 1 week
|
|
the need for a post-pyloric tube
Time Frame: at the patient's ICU discharge, on average 1 week
|
patients who cannot digest with daily NG tube and by doctor decision
|
at the patient's ICU discharge, on average 1 week
|
|
vomitus
Time Frame: at the patient's ICU discharge, on average 1 week
|
in microliters
|
at the patient's ICU discharge, on average 1 week
|
|
diarrhea
Time Frame: at the patient's ICU discharge, on average 1 week
|
in microliters
|
at the patient's ICU discharge, on average 1 week
|
|
constipation days
Time Frame: at the patient's ICU discharge, on average 1 week
|
3 days without stool discharge
|
at the patient's ICU discharge, on average 1 week
|
|
gastrointestinal (GI) bleeding
Time Frame: at the patient's ICU discharge, on average 1 week
|
in number of times
|
at the patient's ICU discharge, on average 1 week
|
|
albumin blood levels
Time Frame: at the patient's ICU discharge, on average 1 week
|
serum albumin blood levels
|
at the patient's ICU discharge, on average 1 week
|
|
Intravenous (IV) injected albumin
Time Frame: at the patient's ICU discharge, on average 1 week
|
IV injected albumin in grams
|
at the patient's ICU discharge, on average 1 week
|
|
heart rate
Time Frame: day 1,3,5,7
|
number of beats per minute
|
day 1,3,5,7
|
|
blood pressure
Time Frame: day 1,3,5,7
|
systolic and diastolic blood pressure in mm Hg
|
day 1,3,5,7
|
|
SpO2 oxygen saturation
Time Frame: day 1,3,5,7
|
Sp02 oxygen saturation levels
|
day 1,3,5,7
|
|
Respiratory rate
Time Frame: day 1,3,5,7
|
measured by number of breath in one minute
|
day 1,3,5,7
|
|
mean arterial pressure
Time Frame: day 1,3,5,7
|
average pressure in a patient's arteries during one cardiac cycle
|
day 1,3,5,7
|
|
Body temperature
Time Frame: at the patient's ICU discharge, on average 1 week
|
number of days of body temperature over 38 °C
|
at the patient's ICU discharge, on average 1 week
|
|
ventilator data
Time Frame: day 1,3,5,7
|
ventilator data
|
day 1,3,5,7
|
|
Overall Satisfaction of patient family
Time Frame: at the patient Hospital discharge, on average 1 month
|
Overall Satisfaction of patient family will be measured by the European Family Satisfaction with Care in the Intensive Care Unit (EURO FS-ICU).
|
at the patient Hospital discharge, on average 1 month
|
|
mechanical ventilation days days
Time Frame: at the patient Hospital discharge, on average 1 month
|
number of days under mechanical ventilation
|
at the patient Hospital discharge, on average 1 month
|
|
ICU stay
Time Frame: at the patient's ICU discharge, on average 1 week
|
number of admission days to the ICU
|
at the patient's ICU discharge, on average 1 week
|
|
hospital days
Time Frame: at the patient Hospital discharge, on average 1 month
|
number of admission days to the hospital
|
at the patient Hospital discharge, on average 1 month
|
|
ICU mortality
Time Frame: at the patient's ICU discharge, on average 1 week
|
number of patients died in the ICU
|
at the patient's ICU discharge, on average 1 week
|
|
Hospital mortality
Time Frame: at the patient Hospital discharge, on average 1 month
|
number of patients died in the hospital
|
at the patient Hospital discharge, on average 1 month
|
|
cost of hospital admission
Time Frame: at the patient Hospital discharge, on average 1 month
|
cost of hospital admission in New Taiwan Dollars {TWD)
|
at the patient Hospital discharge, on average 1 month
|
|
cost of ICU admission
Time Frame: at the patient's ICU discharge, on average 1 week
|
cost of ICU admission in New Taiwan Dollars {TWD).
|
at the patient's ICU discharge, on average 1 week
|
|
acupuncturist blinding
Time Frame: after intervention on day 5
|
blinding questioner will ask the acupuncturist to which group he/she guessed he/she applied the intervention
|
after intervention on day 5
|
Collaborators and Investigators
Investigators
- Principal Investigator: Yu-Chen Lee, China Medical University Hospital
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CMUH110-REC1-037
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Delirium
-
Alexandria UniversityCompletedClozapine Poisoning | Hypoactive Delirium | Tricyclic Antidepressant Poisoning | Anticholinergic Delirium | Antipsychotic Toxicity | CNS Depression | Procyclidine Induced DeliriumEgypt
-
Efficacy Care R&D LtdHadassah Medical OrganizationUnknownDelirium | Delirium, Cause Unknown | Delirium of Mixed Origin | Delirium Confusional State | Delirium Drug-InducedIsrael
-
Duke UniversityNot yet recruitingDelirium Confusional State | Hyperactive Delirium | Delirium in the Intensive Care Unit | Agitated DeliriumUnited States
-
Imperial College Healthcare NHS TrustRecruitingCardiac Surgery | Intensive Care Unit Delirium | Post Operative DeliriumUnited Kingdom
-
Sengkang General HospitalRecruitingDelirium and Post-operative Cognitive Dysfunction (POCD) | Delirium, Postoperative | Delirium - PostoperativeSingapore
-
Oslo University HospitalUniversity of Melbourne; Norwegian Academy of MusicCompletedDelirium in Old Age | Delirium of Mixed Origin | Delirium Superimposed on Dementia | Delirium Confusional StateNorway
-
Universitat de LleidaHospital d'IgualadaNot yet recruitingDelirium in Old Age | Delirium Treatment | Delirium Confusional StateSpain
-
Universidad de SantanderUnknownDelirium of Mixed Origin | Hypoactive Delirium | Hyperactive DeliriumColombia
-
Wonkwang University HospitalCompleted
-
Second Affiliated Hospital of Wenzhou Medical UniversityAffiliated Wenling Hospital of Wenzhou Medical UniversityRecruitingInjection | Delirium in Old Age | Post Operative Delirium | Non-cardiac SurgeryChina
Clinical Trials on pess tack acupuncture
-
Indonesia UniversityCompleted
-
Indonesia UniversityCompletedLactation; Insufficient, Partial | Hypogalactia, Without Mention of Attachment DifficultyIndonesia
-
China Medical University HospitalCompleted
-
China Medical University HospitalRecruitingDelirium | Agitation | Intensive Care Unit DeliriumTaiwan
-
Philips Clinical & Medical Affairs GlobalCompletedPeripheral Artery Disease | Critical Limb IschemiaAustria
-
Shaare Zedek Medical CenterNot yet recruitingSarcoma | Febrile Neutropenia | Doxorubicin Adverse Reaction | Hospitalization-Associated InfectionIsrael
-
Philips Clinical & Medical Affairs GlobalCompletedPeripheral Artery Disease | Critical Limb IschemiaParaguay
-
Philips Clinical & Medical Affairs GlobalCompletedPeripheral Arterial DiseaseUnited States, Germany, New Zealand, Hungary, Austria, Czechia
-
Philips Clinical & Medical Affairs GlobalCompletedPeripheral Artery DiseaseUnited States, Austria, Netherlands
-
Xiaomei ShaoHangzhou Hospital of Traditional Chinese MedicineRecruitingDiminished Ovarian ReserveChina